WEIKANG BIO-TECHNOLOGY GROUP CO., INC. — key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2011)

$101.7M

Net Income/Loss (FY2011)

$29.6M

Total Assets (FY2011)

$123.2M

Total Equity (FY2011)

$112.1M

Cash Flows from Operating Activities (FY2011)

$30.5M

Source: WEIKANG BIO-TECHNOLOGY GROUP CO., INC. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.